Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1741547rdf:typepubmed:Citationlld:pubmed
pubmed-article:1741547lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C0024128lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C0450127lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C0035015lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C0449297lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C1882923lld:lifeskim
pubmed-article:1741547lifeskim:mentionsumls-concept:C1548437lld:lifeskim
pubmed-article:1741547pubmed:issue6lld:pubmed
pubmed-article:1741547pubmed:dateCreated1992-1-9lld:pubmed
pubmed-article:1741547pubmed:abstractTextTo investigate whether lung 99mTc-DTPA clearance is altered during allograft lung rejection, a group of four double lung and 24 heart-lung transplant patients was studied using serial measurement of the clearance rate of aerosolized 99mTc-DTPA (DTPA-Cl), in association with pulmonary function tests, bronchoalveolar lavage, and transbronchial lung biopsies. Using histologic diagnosis as a standard, we compared 56 episodes with normal lung histology to 32 episodes with allograft lung rejection. A control group of 20 healthy nonsmokers was used to define normal DTPA-Cl. In patients with normal lung histology, DTPA-Cl was higher than in control subjects (2.62 +/- 0.25 versus 1.20 +/- 0.12 %/min; p less than 0.001). In the episodes of allograft lung rejection, DTPA-Cl increased to 3.65 +/- 0.41 %/min (p less than 0.02) as compared with episodes of normal lung histology. The change in DTPA-Cl during allograft lung rejection was correlated (r = 0.3, p less than 0.01) with the increased percentage of lymphocytes in bronchoalveolar lavage (27.8 +/- 3.5% in rejection versus 19.9 +/- 2.2% in normal histology; p less than 0.02). Sensitivity and specificity of DTPA-Cl measurement in detecting lung rejection were 69 and 82%, respectively, versus 45 and 85% for FEV1 measurement. These results suggest that DTPA-Cl monitoring could be used in conjunction with pulmonary function testing as a noninvasive approach for the detection of lung rejection.lld:pubmed
pubmed-article:1741547pubmed:languageenglld:pubmed
pubmed-article:1741547pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1741547pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1741547pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1741547pubmed:statusMEDLINElld:pubmed
pubmed-article:1741547pubmed:monthDeclld:pubmed
pubmed-article:1741547pubmed:issn0003-0805lld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:RaisOOlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:CerrinaJJlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:SilbertDDlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:LafontDDlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:DartevellePPlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:ChapelierAAlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:MenschJJlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:BavouxEElld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:LadurieF LFLlld:pubmed
pubmed-article:1741547pubmed:authorpubmed-author:HerveP APAlld:pubmed
pubmed-article:1741547pubmed:issnTypePrintlld:pubmed
pubmed-article:1741547pubmed:volume144lld:pubmed
pubmed-article:1741547pubmed:ownerNLMlld:pubmed
pubmed-article:1741547pubmed:authorsCompleteNlld:pubmed
pubmed-article:1741547pubmed:pagination1333-6lld:pubmed
pubmed-article:1741547pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:meshHeadingpubmed-meshheading:1741547-...lld:pubmed
pubmed-article:1741547pubmed:year1991lld:pubmed
pubmed-article:1741547pubmed:articleTitleIncreased lung clearance of 99mTcDTPA in allograft lung rejection. The Paris-Sud Lung Transplant Group.lld:pubmed
pubmed-article:1741547pubmed:affiliationService de Chirugie Thoracique et de Médecine Nuclélaire, Hopital Marie-Lannelongue et Service de Pneumologie, Hopital Antoine Béclère, Université Paris-Sud, France.lld:pubmed
pubmed-article:1741547pubmed:publicationTypeJournal Articlelld:pubmed